Bernoulli CNO Discusses Innovation and Technology at Villanova Health Summit

/in /by

Jeanne Venella talks with Matt Birnholz about the importance of integrating new technologies within the nursing field.

At the Villanova Health Summit, Jeanne Venella, Chief Nursing Officer of Bernoulli, was interviewed by Dr. Matt Birnholz, Vice President and Medical Director for ReachMD, about the challenges of adopting and integrating new technology into nursing workflow.

Venella stressed the importance of including nurses in healthcare technology evaluation, implementation and training. If end-users are not involved in the selection, adoption and implementation of a technology, then the likelihood that they will become owners of that product is significantly lower, which could impair patient safety and clinical workflow initiatives.

The Villanova Health Summit brings together renowned leaders in the healthcare community representing diverse points of expertise such as bioengineering, law, ethics, hospital administration, bench-to-bedside research, and patient care. Featuring unique, multi-disciplinary collaborations, this series explores novel approaches to some of the most pressing issues in healthcare today.

Click to watch the video interview with Bernoulli’s CNO Jeanne Venella on Reach MD Radio

Janet Dillione named one of Medtech’s Women to know

/in , /by

Bernoulli’s CEO, Janet Dillione, one of Medtech ‘s Women to Know in 2017.

janet dillione medtech women to know in healthcare fieldJanet Dillione, CEO of Bernoulli named one of Becker’s Hospital Review’s “ Medtech Women to Know”. This is a prestigious recognition honoring select women in the healthcare field industry. This is a prestigious recognition honoring select women in the healthcare field industry.  This dynamic group of 110 women executives are sharing ideas and shaping the future of healthcare IT, Medical Devices and Technology with real-life solutions to the most challenging issues facing the healthcare industry today.

According to a 2012 Forbes article, only 4% of healthcare CEOs are women yet female led companies are leading the change in healthcare field. Perhaps it is because women traditionally make more than 80% of healthcare decisions.

Janet Dillione’s professional life is dedicated to the healthcare industry.

She has been at the helm at making significant cutting edge changes that have resulted in positive impacts to healthcare in general. Her many awards include “17 Female Health IT Company CEOs to Know” , “Top 25 Women in Healthcare”, and “One of the Most Powerful Women in the Technology”. These articles reinforce Janet Dillione as a recognized inspiration to women in the industry.

Ms. Dillione’s passion for improving healthcare and her drive for excellence has been repeatedly demonstrated throughout her successful 25 year career in Health Services.

Ms. Dillione supports efforts to improve the quality and safety of healthcare delivery and technology’s role.  Proof can be seen in her drive for patient safety. She continuously puts Bernoulli front and center in its focus on the real-time connected healthcare platform that combines comprehensive and vendor agnostic medical device integration with powerful middleware, clinical surveillance, telemedicine/virtual ICU, advanced alarm management, predictive analytics and robust distribution capabilities.

Their Bernoulli One™ platform empowers clinicians with the tools like medical device integration, alarm management, virtual ICU, clinical surveillance, and analytics as a total solution that improves the patient experience and patient safety.

You find out more about the Bernoulli One™ platform go to http://bernoullihealth.com/

To see the entire list of 110 women go to http://www.beckershospitalreview.com/lists/110-women-in-medtech-to-know-2017.html

Bernoulli Launches Respiratory Depression Safety Surveillance ( RDSS ) Solution

/in , /by

Revolutionary New Analytics Application to Address Significant Patient Safety Threat

Milford, CT—April 3, 2017—Bernoulli, the leader in real-time solutions for patient safety, has announced a revolutionary new application for the continuous monitoring of patients at risk of respiratory depression. Bernoulli’s Respiratory Depression Safety Surveillance (RDSS) solution utilizes comprehensive real-time data to help clinicians quickly recognize and respond to signs of respiratory distress. RDSS includes exclusive analytics with multi-variable thresholds—adjustable by the care facility—to identify clinically actionable events while significantly reducing the overall number of alarms communicated to remote and mobile clinicians, mitigating the risk of alarm fatigue.

A Solution to a Growing Patient Safety Threat

More than half of medication-related deaths and 20,000 incidences of respiratory depression-related interventions annually are attributed to the delivery of opioids in a care setting, at a cost of approximately $2 billion per year to the U.S. healthcare system.1

Current monitoring practices are neither adequate nor comprehensive. For example, one of the most common methods—periodic physical spot checks by direct-care clinical staff—can leave patients unmonitored up to 96% of the time.2 Additionally, the adoption of continuous respiratory surveillance is beset by significant challenges, including reduced visual and audible oversight due to single-patient rooms and high nurse-to-patient ratios in many care areas with at-risk patients, and limitations of stand-alone respiratory monitoring devices that can have high rates of false and non-clinically actionable alarms. The disruption of direct-care clinical staff workflow also is a major barrier to continuous monitoring.

Bernoulli’s RDSS solution mitigates many of these clinical, technical and operational challenges. The platform provides connectivity to a hospital’s existing fleet of pulse oximeters and capnographs from a wide range of vendors, including Medtronic, Masimo and others. RDSS also integrates with mobile clinical communication tools to deliver the right alarms and alerts to the right caregiver at the right time.

Proven Clinical Results

In a forthcoming clinical study of patients diagnosed or at risk of obstructive or central sleep apnea, to be published in the Journal of Biomedical Instrumentation & Technology3, the use of Bernoulli’s RDSS analytics reduced 22,812 alarms generated by bedside capnographs and pulse oximeters to just 209 respiratory depression alerts delivered to mobile clinicians—a reduction of 99%. More importantly, the RDSS analytics distributed alerts for every patient that experienced an actual respiratory depression episode.

“The risks inherent in delivering opioids or patient-controlled analgesia to post-operative patients increase the possibility for sentinel events, particularly in patient populations managing chronic illnesses or co-morbidities, such as sleep apnea and obesity,” said Janet Dillione, CEO of Bernoulli. “Bernoulli’s RDSS solution effectively delivers on the recommendations of The Joint Commission, AAMI Foundation and ECRI Institute that hospitals implement continuous respiratory monitoring for these at-risk patients.”

References

  1. Overdyk FJ, Carter R, Maddox RR, Callura J, Herrin AE, Henriquez C. Continuous Oximetry / Capnometry Monitoring Reveals Frequent Desaturation and Bradypnea During Patient-Controlled Analgesia. Anesth Analg. 2007;105:412-8.
  2. Wong M, Mabuyi A, Gonzalez B. First National Survey of Patient-Controlled Analgesia Practices. Physician-Patient Alliance for Health & Safety (PPAHS), October 2013; Web page: premiersafetyinstitute.org/wp-content/uploads/PPAHS-national-survey-patient-controlled-analgesia.pdf.
  3. Supe D, Baron L, Decker T, Parker K, Venella J, Williams S, Beaton K, Zaleski J. A pilot study in middleware-filtered capnography alarms of continuously monitored obstructive sleep apnea patient in a medical-surgical unit. BI&T. May/June 2017. Manuscript in preparation.

 

About Bernoulli

Bernoulli is the leader in real-time solutions for patient safety, with more than 1,200 installed, operational systems. Bernoulli One™ is the market’s only real-time, connected healthcare platform that combines comprehensive and vendor-neutral medical device integration with powerful middleware, clinical surveillance, telemedicine/virtual ICU, advanced alarm management, predictive analytics and robust distribution capabilities into ONE solution that empowers clinicians with tools to drive better patient safety, clinical outcomes, patient experience, and provider workflow. For more information about Bernoulli One™, visit www.bernoullihealth.com. Follow us on Twitter and LinkedIn. Visit our Resource Center to download case studies, white papers and articles.

Bernoulli Launches Respiratory Depression Safety Surveillance Solution

/in , /by

Revolutionary New Analytics Application to Address Significant Patient Safety Threat

Milford, CT—April 3, 2017—Bernoulli, the leader in real-time solutions for patient safety, has announced a revolutionary new application for the continuous monitoring of patients at risk of respiratory depression. Bernoulli’s Respiratory Depression Safety Surveillance (RDSS) solution utilizes comprehensive real-time data to help clinicians quickly recognize and respond to signs of respiratory distress. RDSS includes exclusive analytics with multi-variable thresholds—adjustable by the care facility—to identify clinically actionable events while significantly reducing the overall number of alarms communicated to remote and mobile clinicians, mitigating the risk of alarm fatigue.

A Solution to a Growing Patient Safety Threat

More than half of medication-related deaths and 20,000 incidences of respiratory depression-related interventions annually are attributed to the delivery of opioids in a care setting, at a cost of approximately $2 billion per year to the U.S. healthcare system.1

Current monitoring practices are neither adequate nor comprehensive. For example, one of the most common methods—periodic physical spot checks by direct-care clinical staff—can leave patients unmonitored up to 96% of the time.2 Additionally, the adoption of continuous respiratory surveillance is beset by significant challenges, including reduced visual and audible oversight due to single-patient rooms and high nurse-to-patient ratios in many care areas with at-risk patients, and limitations of stand-alone respiratory monitoring devices that can have high rates of false and non-clinically actionable alarms. The disruption of direct-care clinical staff workflow also is a major barrier to continuous monitoring.

Bernoulli’s RDSS solution mitigates many of these clinical, technical and operational challenges. The platform provides connectivity to a hospital’s existing fleet of pulse oximeters and capnographs from a wide range of vendors, including Medtronic, Masimo and others. RDSS also integrates with mobile clinical communication tools to deliver the right alarms and alerts to the right caregiver at the right time.

Proven Clinical Results

In a forthcoming clinical study of patients diagnosed or at risk of obstructive or central sleep apnea, to be published in the Journal of Biomedical Instrumentation & Technology3, the use of Bernoulli’s RDSS analytics reduced 22,812 alarms generated by bedside capnographs and pulse oximeters to just 209 respiratory depression alerts delivered to mobile clinicians—a reduction of 99%. More importantly, the RDSS analytics distributed alerts for every patient that experienced an actual respiratory depression episode.

“The risks inherent in delivering opioids or patient-controlled analgesia to post-operative patients increase the possibility for sentinel events, particularly in patient populations managing chronic illnesses or co-morbidities, such as sleep apnea and obesity,” said Janet Dillione, CEO of Bernoulli. “Bernoulli’s RDSS solution effectively delivers on the recommendations of The Joint Commission, AAMI Foundation and ECRI Institute that hospitals implement continuous respiratory monitoring for these at-risk patients.”

References

  1. Overdyk FJ, Carter R, Maddox RR, Callura J, Herrin AE, Henriquez C. Continuous Oximetry / Capnometry Monitoring Reveals Frequent Desaturation and Bradypnea During Patient-Controlled Analgesia. Anesth Analg. 2007;105:412-8.
  2. Wong M, Mabuyi A, Gonzalez B. First National Survey of Patient-Controlled Analgesia Practices. Physician-Patient Alliance for Health & Safety (PPAHS), October 2013; Web page: premiersafetyinstitute.org/wp-content/uploads/PPAHS-national-survey-patient-controlled-analgesia.pdf.
  3. Supe D, Baron L, Decker T, Parker K, Venella J, Williams S, Beaton K, Zaleski J. A pilot study in middleware-filtered capnography alarms of continuously monitored obstructive sleep apnea patient in a medical-surgical unit. BI&T. May/June 2017. Manuscript in preparation.

 

About Bernoulli

Bernoulli is the leader in real-time solutions for patient safety, with more than 1,200 installed, operational systems. Bernoulli One is the market’s only real-time, connected healthcare platform that combines comprehensive and vendor-neutral medical device integration with powerful middleware, clinical surveillance, telemedicine/virtual ICU, advanced alarm management, predictive analytics and robust distribution capabilities into ONE solution that empowers clinicians with tools to drive better patient safety, clinical outcomes, patient experience, and provider workflow. For more information about Bernoulli One, visit www.bernoullihealth.com. Follow us on Twitter and LinkedIn. Visit our Resource Center to download case studies, white papers and articles.

John Zaleski to Present at Machine Learning & AI in Healthcare Conference

/in /by

Bernoulli Chief Analytics Officer John Zaleski, PhD, CAP, CPHIMS, will be presenting “Identifying actionable alarms in OSA patients receiving opioids” at the Machine Learning & AI in Healthcare conference May 3-4, in Boston.

 

ecn-machine2017

Dr. Zaleski will discuss the use of adjustable, multi-variable thresholds involving combinatorial alarm signals to discriminate between actionable and non-actionable alarms without increasing risks to patient safety.

“Middleware designed to collect data at variable speeds and the use of precision alarms, which harness real-time patient data and notifications from individual devices in order to identify clinically relevant trends, sustained conditions and combinatorial indications are essential to continuous electronic monitoring (CEM),” said Zaleski.

Considered a best practice by the Joint Commission, the Anesthesia Patient Safety Foundation and other healthcare advocates and agencies, CEM is typically utilized in high-acuity settings, such as intensive care and med-surg units. However, the ability to combine analysis with real-time data at the point of collection makes enterprise-wide CEM a viable opportunity. “The ability to track patients throughout the hospital, continuously add new medical devices, and distribute real-time patient data to centralized dashboards and mobile devices should be a major consideration for health system seeking to achieve real-time healthcare capabilities,” he said.

Zaleski’s session is scheduled for 10 a.m. (ET) on May 4. The conference updates and news will be available on Twitter using the hashtag #MachineLearningHC.

Follow Bernoulli on Twitter and LinkedIn. Visit our Resource Center to download case studies, white papers and articles.

Why continuous monitoring will challenge CIOs and their IT systems

/in , /by

CEO Janet Dillione published in Health Data Management

hdmThe successful implementation of scalable, real-time patient safety initiatives have long been a goal of hospitals and health system CIOs, which is why understanding the value proposition of alarm and notification platforms is essential familiarity of health system CIOs, writes Bernoulli CEO Janet Dillione in Health Data Management.

“The ability to track patients throughout the hospital, continuously add new devices, and distribute real-time patient monitoring to centralized dashboards and mobile devices should be a major consideration for CIOs tasked with implementing real-time healthcare solutions,” Dillione writes.

Health system CIOs should evaluate medical device integration middleware capabilities, precision alarms, and real-time analytics driven by a rules-based engine.

Dillione concludes that health systems that can establish continuous electronic monitoring are creating a foundation real-time healthcare innovations, including clinical surveillance modules, medical device integration in an EHR and virtual ICUs.

Follow Bernoulli on LinkedIn and Twitter for the latest news and updates.

Jeanne Venella’s Alarm Fatigue Commentary in AAMI Horizons

/in , /by

jeanne VenellaAlarm signals are disrupting patients’ recovery and exhausting clinical staff, according to a commentary published by Bernoulli Chief Nursing Officer Jeanne Venella, DNP, MS, RN, CEN, CPEN, in the Spring 2017 issue of AAMI Horizons.

“Drawing Up a New Game Plan to Reduce Alarm Fatigue” notes that 85 percent to 99 percent of alarms require no intervention on the part of clinical staff. In addition to alarm fatigue, this growing problem represents a significant risk to patient safety if caregivers arbitrarily adjust threshold settings on devices or shut them off completely.

The problem has become so severe that the Joint Commission made clinical alarm management a priority with its National Patient Safety Goal (NPSG.06.01.01), mandating that hospitals take definitive steps to implement policies and procedures to safely reduce and prioritize clinical alarms.

Venella explores the logical steps hospitals and health systems should take to get their alarm issue under control, including:

  • Assessing the current state of the clinical alarm environment, identifying and developing targets for reduction, and evaluating appropriate interventions, policies, and standards.
  • Performing a baseline alarm management study to separate clinically relevant alarms from non-actionable alarms and managing the ever-growing number of alarm-enabled medical devices.
  • Devising standards and strategies for executing on a clinical alarm management program

Writes Venella, “Alarm management is a classic example of interdisciplinary leadership, involving clinical, IT, biomedical engineering, and other departments. Alarm management is also much more than simply reducing non-actionable alarms; it’s a gateway for more seamless care and a way for hospitals to leverage hard data to make continuous improvements to its care and response processes.”

 

The Spring issue of AAMI Horizons is now online for AAMI members and subscribers. Follow Bernoulli on LinkedIn and Twitter for the latest news and updates.

Continuous Monitoring of Patients at Risk for Respiratory Depression

/in , /by

Bernoulli CNO and CAO co-author article on continuous monitoring of patients at risk for respiratory depression published in AAMI Horizons Spring 2017 issue

AAMI Horizons 2017The use of middleware for the continuous monitoring of patients at risk of respiratory depression was the subject of a paper just published by Bernoulli Chief Analytics Officer John Zaleski, PhD, CAP, CPHIMS, and Chief Nursing Officer Jeanne Venella, DNP, MS, RN, CEN, CPEN, in the Spring 2017 issue of AAMI Horizons.

“Using Middleware to Manage Smart Alarms for Patients Receiving Opioids” explores the risks hospitals and health systems are exposed to due to inadequate monitoring of post-operative patients who receive opioids.

Although continuous monitoring of these patient populations is recommended as a best practice by the Joint Commission, Anesthesia Patient Safety Foundation, the Association for the Advancement of Medical Instrumentation, and other healthcare advocates and governing agencies. However, continuous monitoring of these patient populations, particularly outside the critical care unit setting, remains the exception to the rule.

Why? The adoption of this best practice is beset by significant business and clinical challenges, including the implementation of costly physiologic device technology, the possible addition of full-time direct-care clinical staff, and the difficulty of capturing holistic, real-time patient data in order to facilitate early intervention.

Zaleski and Venella explore the viability of comprehensive and cost-effective solutions, including:

  • The use of Smart Alarm technology to provide caregivers with an accurate, real-time picture of a patient’s condition, while attenuating alarm signals that communicate contextual patient-safety specific information and minimize spurious signals that can lead to alarm fatigue.
  • Leveraging multi-parameter physiologic monitors—such as capnography and pulse oximetry—as a sensitive and early indicator of opioid-induced respiratory depression.
  • Assessing the core standards required of device-agnostic middleware platforms for interfacing with bedside devices and combining it with other data from the patient record to create a more holistic and complete picture of the current patient state.

Write the authors: “Combining analysis with real-time data collection at the point of collection creates a powerful tool for prediction and decision support, particularly if this tool can also integrate data from other sources (e.g.: laboratory, electronic health record) to bring more context to bear relative to the patient under consideration.”

The Spring issue of AAMI Horizons is now online for AAMI members and subscribers. Follow Bernoulli on LinkedIn and Twitter for the latest news and updates.

Team-based approach to health IT implementations

/in /by

CNO Jeanne Venella published in Minority Nurse

jeanne VenellaToo many hospitals fail to include front-line clinical staff in health IT projects, leading to poor technology adoption or implementation failure, writes Bernoulli Chief Nursing Officer Jeanne Venella, DNP, MS, RN, CEN, CPEN, in an article published in Minority Nurse.

Hospitals have dedicated tremendous resources to create an integrated clinical environment that results in better patient treatment and outcomes, reduces readmissions and hospital utilization, and bends the overall cost of healthcare down.

Unfortunately, health IT projects either fall short of business and clinical goals or are completely abandoned at an astonishing rate. Studies vary, but failure-rate estimates range from 35 percent to 75 percent.

Venella argues that fostering a team of internal champions from a myriad of departments – including patient-facing clinical staff – significantly increases the chances of a sustainable health IT solution.

Writes Venella, “The seamless integration of technology requires that patient-facing clinical staff have influence in the design and testing of equipment and applications. Involving end-users in the early stages of system analysis and design specifications can lead to better adoption of new technology, as well as identifying how current technology can be adapted for greater user acceptance.”

Venella also recently hosted a Bernoulli-sponsored webinar on the topic of team-based approaches to technology adoption. The archived webinar can be found here.

 

Follow Bernoulli on LinkedIn and Twitter for the latest news and updates.

Physician Advisors to Consult on Real-Time Healthcare & Patient Safety Issues

/in , , /by

Expertise will Provide Valuable Insights on Supporting Clinical Workflow and Driving Improved Quality of Care

Milford, CT—March 27, 2017—Bernoulli, the leader in real-time solutions for patient safety, announced that two prominent physicians will join the company as consultants to explore issues related to real-time healthcare delivery and increased patient safety.

Neil A. Halpern, MD, MCCM, FCCP, FACP, is Director of the Critical Care Center, Chief of the Critical Care Medicine Service and Medical Director of Respiratory Therapy at Memorial Sloan Kettering (MSK) Cancer Center in New York. Dr. Halpern oversees a team of highly experienced doctors, nurse practitioners, physician assistants, respiratory therapists, research and bedside nurses, and critical care programmers who help provide care for patients in MSK’s adult medical-surgical intensive care unit (ICU).

Since 2000, he has co-chaired the hospital’s Clinical Device and Product Evaluation Committee, and since 2014, the Alarm Committee at MSK. Between 2005 and 2007, he chaired the multidisciplinary ICU Design Committee that developed the plan and monitored the construction of MSK’s 20-bed medical-surgical adult ICU, which opened in April 2007.

“There is a clear need in healthcare for greater connectivity, interoperability and comprehensive real-time data to support improved patient safety, enhanced care team collaboration and proactive clinical intervention,” said Dr. Halpern. “I look forward to advising Bernoulli on the applications and services that will have the greatest impact.”

Amar Setty, MD, is the CEO of AnesthesiaStat, a Baltimore-based anesthesia consulting and management company operated by practicing, Board Certified anesthesiologists. In addition to an active private practice, Dr. Setty serves as the immediate-Past President of the Maryland Society of Anesthesiologists, where he continues to be an advocate.

He is working to develop data-centric applications for patient-advocated value-based care, ultrasound/video-based artificial intelligence for medical procedures, as well as an app for patient empowerment in chronic pain. He has a unique interest in the use of technology to improve the perioperative experience and is working to build a new system of surgical risk prediction and management. He hopes to improve the quality and care of patients before and after discharge.

“The complexity and exponential growth of patient-generated data in modern care settings can be overwhelming, and even act as a barrier to real-time patient care and interventions if not properly managed,” said Dr. Setty. “I am excited to sharing my perspectives and experiences as a physician with Bernoulli to better facilitate the use of comprehensive real-time patient data to improve patient safety, quality and cost of care.”

“Many of the challenges facing healthcare providers – including mitigating patient safety threats, embarking on value-based care initiatives, and streamlining clinical workflows – require comprehensive real-time data, surveillance and analytics,” said Janet Dillione, CEO of Bernoulli. “Dr. Setty and Dr. Halpern’s clinical expertise will help uncover valuable insights, enabling us to better align our solutions with the needs of hospitals and health systems.”

 

About Bernoulli

Bernoulli is the leader in real-time solutions for patient safety, with more than 1,200 installed, operational systems. Bernoulli One™ is the market’s only real-time, connected healthcare platform that combines comprehensive and vendor-neutral medical device integration with powerful middleware, clinical surveillance, telemedicine/virtual ICU, advanced alarm management, predictive analytics and robust distribution capabilities into ONE solution that empowers clinicians with tools to drive better patient safety, clinical outcomes, patient experience, and provider workflow. For more information about Bernoulli, visit www.bernoullihealth.com. Follow us on Twitter and LinkedIn. Visit our Resource Center to download case studies, white papers and articles.